Manufacture of Isonic, Azide-Free Blood Diluting Solution

The contract requires the manufacture of 20-liter batches of an isonic, azide-free blood diluting solution specifically designed for the accurate counting of red and white blood cells, with strict adherence to DLA technical standards to ensure consistency, safety, and performance in clinical and laboratory settings. The product must be free of azide compounds, aligning with modern biosafety and environmental handling requirements, and produced under conditions that maintain structural integrity and biological compatibility for hematological applications. The solicitation is issued as a subcontract under the DLA’s Medical Supply Chain division, with a response deadline of August 10, 2026, and a posting date of August 2, 2026. The North American Industry Classification System code 325412 indicates the work falls under pharmaceutical and medicine manufacturing. Performance is to be executed with the place of performance listed as FPO with ZIP code 96694, indicating delivery to a military or federal facility, likely supporting U.S. military medical operations. The contract is managed under the Department of Defense, and interested parties must respond through the designated DIBBS portal prior to the deadline to be considered.